The obtained results suggest that the major source of IDO in the tumor microenvironment are granulocytic CD11b+Ly6G+ myeloid cells that strongly infiltrate the tumor after treatment and reveal the highest expression levels of this enzyme. Here, IDO1 is linked to neoplasm.